- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 19.02. | Amplex AB announces final outcome in the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 2 | Cision News | ||
| 18.02. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 18.02.2026 | 877 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 18.02.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 18.02.2026ISIN NameDE000A31C3Y4 ALTECH... ► Artikel lesen | |
| 18.02. | XFRA Q3I: AUSSETZUNG/SUSPENSION | 142 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILADDVISE GROUP AB... ► Artikel lesen | |
| 16.02. | ADDvise Group AB (publ): Resolutions at the extraordinary general meeting in ADDvise Group AB (publ) | 190 | GlobeNewswire (Europe) | At the extraordinary general meeting in ADDvise Group AB (publ) ("ADDvise") held today on 16 February 2026, Mia Tomczak and Richard Jernberg were elected as new board members of the company. The resolution... ► Artikel lesen | |
| 13.02. | ADDvise Group AB Profit Retreats In Q4 | 1 | RTTNews | ||
| 12.02. | Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 1 | Cision News | ||
| 12.02. | ADDvise Group AB (publ): Year-end report 2025, January 1-December 31 | 144 | GlobeNewswire (Europe) | Increased profits, profitability and stable cash flow. In the fourth quarter, organic sales increased by 4.0% in constant currency and an increase of 1.5% for the full year 2025. Our focus on operational... ► Artikel lesen | |
| ADDVISE GROUP Aktie jetzt für 0€ handeln | |||||
| 03.02. | ADDvise Group AB (publ): Delisting of the shares and warrants in ADDvise from Nasdaq First North | 139 | GlobeNewswire (Europe) | On 29 January 2026, ADDvise Group AB (publ) ("ADDvise") announced that its board of directors had applied for delisting of the shares and warrants in ADDvise from Nasdaq First North Premier Growth Market... ► Artikel lesen | |
| 29.01. | ADDvise Group AB (publ): ADDvise has applied for delisting of its shares and warrants from Nasdaq First North | 173 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex"), announced a public offer (the "Offer") to the holders of shares and warrants of ADDvise Group AB (publ) ("ADDvise"). On 27 January 2026, Amplex announced that... ► Artikel lesen | |
| 27.01. | Amplex AB becomes the owner of 94.31 per cent of the shares in ADDvise, extends the acceptance period and intends to initiate compulsory redemption and promote delisting | 1 | Cision News | ||
| 19.01. | Amplex AB has obtained all approvals from authorities for the offer to the shareholders and warrantholders of ADDvise Group AB (publ) and declares the offer unconditional | 1 | Cision News | ||
| 14.01. | ADDvise Group AB (publ): ADDvise announces financial update for 2025 | 146 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the holders of shares and warrants in ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all their... ► Artikel lesen | |
| 05.01. | ADDvise Group AB (publ): Statement from the independent bid committee of ADDvise in relation to the public offer from Amplex | 186 | GlobeNewswire (Europe) | The independent bid committee of ADDvise recommends that holders of shares and warrants who have a short-term perspective on their ownership or who do not wish to be owners in a listed ADDvise with... ► Artikel lesen | |
| 02.01. | ADDvise Group AB (publ): ADDvise initiates a written procedure under its outstanding bonds 2025/2028 in light of the public offer from Amplex | 357 | GlobeNewswire (Europe) | ADDvise Group AB (publ) (the "Company" or "ADDvise") has instructed the agent under the Company's outstanding bonds 2025/2028 with ISIN SE0025011885 (the "Bonds") to initiate a written procedure in... ► Artikel lesen | |
| 30.12.25 | AMPLEX AB: Amplex enters into additional agreements on conditional acquisitions of shares and warrants in ADDvise | 2 | Cision News | ||
| 19.12.25 | ADDvise Group AB (publ): Amplex has increased the consideration in the public offer to the shareholders and warrant holders of ADDVise | 147 | GlobeNewswire (Europe) | On 10 December 2025, Amplex AB ("Amplex" or the "Bidder") announced a public offer to the shareholders and warrant holders of ADDvise Group AB (publ) ("ADDvise" or the "Company") to transfer all shares... ► Artikel lesen | |
| 19.12.25 | Amplex AB publishes supplement to the offer document regarding the cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 1 | Cision News | ||
| 19.12.25 | AMPLEX AB: Amplex increases the consideration in the cash offer to the shareholders and warrantholders of ADDvise and enters into agreements on conditional acquisitions of shares and warrants in ADDvise | 3 | Cision News | ||
| 10.12.25 | ADDvise Group AB (publ) receives observation status | 406 | GlobeNewswire | Today, December 10, 2025, Amplex AB disclosed a public offer to the other shareholders and equity rights holders of ADDvise Group AB (publ).
The rules of Nasdaq First North Growth Market state... ► Artikel lesen | |
| 10.12.25 | AMPLEX AB: Amplex publishes the offer document for the public cash offer to the shareholders and warrantholders of ADDvise Group AB (publ) | 4 | Cision News |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 39,290 | -0,91 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 38,680 | +1,02 % | Multinational Execs in China Must Act as Entrepreneurs, Siemens Healthineers Country President Says | ||
| CARL ZEISS MEDITEC | 27,400 | +1,11 % | Carl Zeiss Meditec AG: Margendruck und strukturelle Unsicherheiten bestehen weiterhin. Kursziel gesenkt, HALTEN. | Die schwachen Ergebnisse von Carl Zeiss Meditec (CZM) für das erste Quartal des Geschäftsjahres 2025/26, die im Februar veröffentlicht wurden, sind weitgehend verarbeitet worden, jedoch schränkt der... ► Artikel lesen | |
| UNITEDHEALTH | 266,20 | -0,15 % | UnitedHealth Group-Aktie mit +9% - Ist die Trendwende gelungen? | Nachdem der Kurs der UnitedHealth Group-Aktie zuletzt unter Druck geraten war und eine Korrekturphase durchlaufen hatte, zeigt sich nun eine Gegenbewegung. Die Erholung bringt neues Momentum in den... ► Artikel lesen | |
| INTUITIVE SURGICAL | 396,10 | -0,04 % | If You Invested $1000 In Intuitive Surgical Stock 10 Years Ago, You Would Have This Much Today | ||
| MEDTRONIC | 74,74 | +0,03 % | Future Market Insights: Global Weight Loss and Obesity Management Market | 12.8% CAGR Growth Trajectory | Asia Pacific, North America Lead | Novo Nordisk, Eli Lilly, Medtronic Drive Integrated Care Evolution | NEWARK, Del., April 9, 2026 /PRNewswire/ -- According to the latest analysis by Future Market Insights, the global weight loss and obesity management market is undergoing a transformative... ► Artikel lesen | |
| THERMO FISHER | 446,70 | -0,13 % | Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities | ||
| TELADOC HEALTH | 4,437 | -0,25 % | Pineal Capital Management Issues Open Letter to the Board of Teladoc Health, Inc. | DUBLIN, March 31, 2026 (GLOBE NEWSWIRE) -- The following is an open letter issued by Pineal Capital Management:
Board of DirectorsTeladoc Health, Inc.2 Manhattanville Road, Suite 203Purchase, NY... ► Artikel lesen | |
| HIMS & HERS HEALTH | 18,130 | -0,06 % | Hims & Hers-Aktie: Neue Chancen nach dem Hype? | Die Aktie von Hims & Hers Health hat nach einer Zeit voller Hype und überschwänglichen Erwartungen in den vergangenen Monaten massiv gelitten. Nach einem deutlichen Kursrückgang rückt nun die Frage... ► Artikel lesen | |
| BICO GROUP | 1,860 | +0,11 % | BICO Group AB: BICO Group AB has divested the Finnish property for a total of EUR 3.5m | BICO Group AB ("BICO") has completed the divestment of its property in Oulu, Finland, through the sale of BICO Real Estate Oy to Logistea AB ("Logistea"). The total sales price amounts to EUR 3.5m,... ► Artikel lesen | |
| EUROFINS SCIENTIFIC | 68,40 | -0,15 % | Eurofins Scientific To Divest Electrical & Electronic Testing Business | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Eurofins Scientific SE (EUFI.PA, ERF.PA) announced the signing of an agreement to divest its Electrical & Electronic Testing business, or MET Labs, to UL... ► Artikel lesen | |
| BECTON DICKINSON | 132,10 | +0,04 % | BD (Becton, Dickinson and Company): BD stellt die nächste Generation der TIPS-Technologie vor, um die Behandlung der portalen Hypertonie in der gesamten Europäischen Union voranzubringen | Dank der CE-Kennzeichnung und der Daten aus der klinischen ARCH-Studie ist der Liverty TIPS Stent Graft in der Lage, die Behandlungsmöglichkeiten für Patienten mit fortgeschrittener Lebererkrankung... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 157,65 | +0,57 % | Aktien New York: Weitere Verluste wegen erneutem Ölpreisschub | NEW YORK (dpa-AFX) - An den New Yorker Aktienmärkten geht es am Donnerstag aus Angst vor einer weiteren Eskalation an den Energiemärkten weiter bergab. Deutlich steigende Öl- und Gaspreise im Zuge... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | +1,85 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| INMODE | 11,810 | -1,46 % | InMode Ltd.: InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million | YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen |
Das Unternehmen ADDVISE GROUP AB kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 0,142 Euro und damit 0,00 % im Plus. Die Dividendendrendite beträgt aktuell 0,00 % (berechnet anhand der Ausschüttung von 0,00 Euro in den letzten 12 Monaten).
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADDVISE GROUP AB finden Sie auf Wallstreet Online.